Neurotransmitters are chemical messengers that let neurons communicate across synapses, linking electrical signals in one cell to chemical signals in another. These systems control movement, mood, attention, sleep, pain, memory, and autonomic function. Understanding the major neurotransmitters helps students connect basic neurobiology to symptoms, drug actions, and disease mechanisms.
It is a core foundation for neuroscience, pharmacology, psychiatry, and clinical medicine.
At a synapse, an action potential triggers Ca2+ entry into the presynaptic terminal, causing vesicles to release neurotransmitter into the synaptic cleft. The transmitter then binds ionotropic or metabotropic receptors on the postsynaptic cell, changing membrane potential or intracellular signaling. The signal ends by reuptake, enzymatic breakdown, or diffusion, and many drugs work by altering one of these steps.
Clinical effects depend on which transmitter is involved, which receptor subtype is activated, and where in the nervous system the pathway is located.
Understanding Neurotransmitter Systems
Neurons do not all use one chemical language. Glutamate is the main fast excitatory transmitter in much of the brain. Gamma aminobutyric acid, often called GABA, provides much of the fast inhibition.
Glycine has a similar role in the spinal cord and brainstem. Acetylcholine, dopamine, serotonin, norepinephrine, histamine, and neuropeptides often shape circuit activity over wider areas or longer periods. A neuron must make its transmitter, load it into vesicles, release it, then clear or recycle it.
Each step needs specific enzymes and transport proteins. A fault at any step can change signaling even when receptors are normal.
Some neurons release more than one messenger. This lets one cell influence a target in several ways.
The label excitatory or inhibitory does not belong permanently to a neurotransmitter. The effect depends on the receptor and on the ions that move when that receptor opens. It also depends on the current voltage of the receiving cell.
For example, GABA usually reduces firing in mature brain neurons. In early development, the same GABA signal can have a different effect because ion gradients have not fully matured. Receptors can sit on the cell body, dendrites, or axon terminal.
A receptor on an axon terminal may reduce release of another transmitter. This is called presynaptic control. It helps circuits adjust their own output and prevents signals from becoming too strong.
Clinical medicine often involves changing transmitter signaling rather than simply adding a missing chemical. In Parkinson disease, loss of dopamine producing neurons reduces useful signaling in movement circuits. Levodopa can raise dopamine production, but its effects depend on surviving neurons and receptor responses.
Many antidepressants slow the reuptake of serotonin or norepinephrine. Their benefits usually take weeks because brain circuits gradually adapt. Benzodiazepines strengthen certain GABA receptor effects, which can reduce anxiety or stop seizures.
They can also cause drowsiness, poor coordination, tolerance, and dependence. Antipsychotic medicines often block dopamine receptors. This may reduce psychotic symptoms, though it can cause movement problems or hormonal changes because dopamine has roles in several pathways.
Students should learn each system as a chain of linked ideas. Know where the transmitter is made, how it is removed, which receptor families respond, and which brain regions use the pathway. Then connect this chain to a symptom or drug effect.
Receptor subtype matters greatly. Nicotinic acetylcholine receptors at skeletal muscle act differently from muscarinic receptors in the heart or gut. Nicotine, caffeine, alcohol, pain medicines, sleep medicines, and some allergy medicines all affect neural signaling in ways people may notice in daily life.
The same drug can help one circuit while disrupting another. That is why side effects are common and why dose, timing, and individual biology matter.
Key Facts
- Synaptic release is triggered when depolarization opens voltage gated Ca2+ channels in the presynaptic terminal.
- Ionotropic receptors are ligand gated ion channels that act in milliseconds, while metabotropic receptors are G protein coupled receptors that act more slowly.
- Excitatory postsynaptic potentials often involve Na+ or Ca2+ entry, while inhibitory postsynaptic potentials often involve Cl- entry or K+ exit.
- Acetylcholine acts at nicotinic receptors in the neuromuscular junction and autonomic ganglia, and at muscarinic receptors in parasympathetic target organs.
- Dopamine pathways include nigrostriatal for movement, mesolimbic for reward, mesocortical for cognition, and tuberoinfundibular for prolactin regulation.
- A common membrane relation is I = g(Vm - Eion), where synaptic current depends on conductance and the difference between membrane potential and ion equilibrium potential.
Vocabulary
- Synapse
- A synapse is the junction where one neuron communicates with another cell by releasing neurotransmitter.
- Neurotransmitter
- A neurotransmitter is a chemical messenger released by a neuron that binds receptors on a target cell.
- Ionotropic receptor
- An ionotropic receptor is a receptor that directly opens an ion channel when a neurotransmitter binds.
- Metabotropic receptor
- A metabotropic receptor is a G protein coupled receptor that changes cell activity through second messenger signaling.
- Reuptake
- Reuptake is the process by which released neurotransmitter is transported back into the presynaptic neuron or nearby glial cells.
Common Mistakes to Avoid
- Assuming one neurotransmitter is always excitatory or always inhibitory, which is wrong because the effect depends on the receptor subtype and target cell ion channels. For example, acetylcholine can excite skeletal muscle but slow the heart through different receptors.
- Confusing ionotropic and metabotropic receptors, which is wrong because they differ in mechanism and time course. Ionotropic receptors directly gate ion flow, while metabotropic receptors signal through G proteins and second messengers.
- Thinking dopamine deficiency causes all dopamine related disorders, which is wrong because too little or too much signaling in different pathways produces different symptoms. Parkinson disease, psychosis, and hyperprolactinemia involve different dopamine circuit problems.
- Ignoring how signals are terminated, which is wrong because reuptake and enzymatic breakdown strongly shape synaptic effects and drug responses. Many important medications act by blocking transporters or enzymes rather than by mimicking the transmitter itself.
Practice Questions
- 1 A synapse releases a neurotransmitter that opens a postsynaptic Cl- channel. If the postsynaptic membrane potential is -60 mV and ECl is -70 mV, will the membrane tend to depolarize or hyperpolarize when the channel opens? State the direction of change.
- 2 A patient is given a drug that inhibits acetylcholinesterase. If 120 acetylcholine molecules would normally remain in the cleft for 2 ms, predict whether the duration of receptor activation will increase or decrease and explain the likely effect at the neuromuscular junction.
- 3 A drug blocks dopamine D2 receptors in the tuberoinfundibular pathway. Explain why this can raise prolactin levels even though the same drug may reduce psychotic symptoms through a different dopamine pathway.